BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24754711)

  • 1. Syntheses, radiolabelings, and in vitro evaluations of fluorinated PET radioligands of 5-HT6 serotoninergic receptors.
    Colomb J; Becker G; Fieux S; Zimmer L; Billard T
    J Med Chem; 2014 May; 57(9):3884-90. PubMed ID: 24754711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.
    Becker G; Colomb J; Sgambato-Faure V; Tremblay L; Billard T; Zimmer L
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):495-502. PubMed ID: 25331460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligand.
    Tang S; Verdurand M; Joseph B; Lemoine L; Daoust A; Billard T; Fournet G; Le Bars D; Zimmer L
    Nucl Med Biol; 2007 Nov; 34(8):995-1002. PubMed ID: 17998104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical validation of [
    Emery S; Fieux S; Vidal B; Courault P; Bouvard S; Tourvieille C; Iecker T; Billard T; Zimmer L; Lancelot S
    Nucl Med Biol; 2020; 82-83():57-63. PubMed ID: 32006785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Expression of 5-HT6 Receptor at Different Stages of Alzheimer's Disease: A Postmortem Study with the PET Radiopharmaceutical [18F]2FNQ1P.
    Courault P; Emery S; Bouvard S; Liger F; Chauveau F; Meyronet D; Fourier A; Billard T; Zimmer L; Lancelot S
    J Alzheimers Dis; 2020; 75(4):1329-1338. PubMed ID: 32417774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging.
    Colomb J; Becker G; Forcellini E; Meyer S; Buisson L; Zimmer L; Billard T
    Nucl Med Biol; 2014 Apr; 41(4):330-7. PubMed ID: 24607435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of positron emission tomography radiotracers for serotonin receptors in humans.
    Zimmer L; Le Bars D
    J Labelled Comp Radiopharm; 2013; 56(3-4):105-13. PubMed ID: 24285316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography.
    Prasad VP; Wagner S; Keul P; Hermann S; Levkau B; Schäfers M; Haufe G
    Bioorg Med Chem; 2014 Oct; 22(19):5168-81. PubMed ID: 25216968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptor.
    Parker CA; Gunn RN; Rabiner EA; Slifstein M; Comley R; Salinas C; Johnson CN; Jakobsen S; Houle S; Laruelle M; Cunningham VJ; Martarello L
    J Nucl Med; 2012 Feb; 53(2):295-303. PubMed ID: 22223878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers.
    Andries J; Lemoine L; Le Bars D; Zimmer L; Billard T
    Eur J Med Chem; 2011 Aug; 46(8):3455-61. PubMed ID: 21620533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking for a 5-HT7 radiotracer for positron emission tomography.
    Andriès J; Lemoine L; Mouchel-Blaisot A; Tang S; Verdurand M; Le Bars D; Zimmer L; Billard T
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3730-3. PubMed ID: 20471259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and Reliability of [
    Sgambato-Faure V; Billard T; Météreau E; Duperrier S; Fieux S; Costes N; Tremblay L; Zimmer L
    Front Pharmacol; 2017; 8():471. PubMed ID: 28769801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [
    Philippe C; Zeilinger M; Dumanic M; Pichler F; Fetty L; Vraka C; Balber T; Wadsak W; Pallitsch K; Spreitzer H; Lanzenberger R; Hacker M; Mitterhauser M
    Mol Imaging Biol; 2019 Apr; 21(2):257-268. PubMed ID: 29948643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
    Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
    Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies.
    Guenther KJ; Yoganathan S; Garofalo R; Kawabata T; Strack T; Labiris R; Dolovich M; Chirakal R; Valliant JF
    J Med Chem; 2006 Feb; 49(4):1466-74. PubMed ID: 16480283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.
    Schaffhauser H; Mathiasen JR; Dicamillo A; Huffman MJ; Lu LD; McKenna BA; Qian J; Marino MJ
    Biochem Pharmacol; 2009 Oct; 78(8):1035-42. PubMed ID: 19549510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in Vitro Actions of Loxapine on Dopaminergic and Serotonergic Receptors. Time to Consider Atypical Classification of This Antipsychotic Drug?
    Ferreri F; Drapier D; Baloche E; Ouzid M; Zimmer L; Llorca PM
    Int J Neuropsychopharmacol; 2018 Apr; 21(4):355-360. PubMed ID: 29106549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.